Page last updated: 2024-08-07 17:04:54

Glutamate receptor ionotropic, NMDA 2B

A glutamate receptor ionotropic, NMDA 2B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13224]

Synonyms

GluN2B;
Glutamate [NMDA] receptor subunit epsilon-2;
N-methyl D-aspartate receptor subtype 2B;
NMDAR2B;
NR2B;
N-methyl-D-aspartate receptor subunit 3;
NR3;
hNR3

Research

Bioassay Publications (58)

TimeframeStudies on this Protein(%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (12.07)18.2507
2000's17 (29.31)29.6817
2010's26 (44.83)24.3611
2020's8 (13.79)2.80

Compounds (55)

Drugs with Inhibition Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acidHomo sapiens (human)IC50100.000011
6,7-dichloroquinoxaline-2,3-dioneHomo sapiens (human)IC5042,941.753323
tacrineHomo sapiens (human)IC5044.000022
amantadineHomo sapiens (human)Ki10.500011
arcaineHomo sapiens (human)IC5044.555022
chlorpromazineHomo sapiens (human)IC500.850022
racemethorphanHomo sapiens (human)IC500.365022
ifenprodilHomo sapiens (human)IC500.151999
ifenprodilHomo sapiens (human)Ki0.01001010
ketamineHomo sapiens (human)IC504.105922
ketamineHomo sapiens (human)Ki0.670044
kynurenic acidHomo sapiens (human)IC5015.000011
memantineHomo sapiens (human)IC505.310044
memantineHomo sapiens (human)Ki0.693333
orphenadrineHomo sapiens (human)Ki6.000011
procyclidineHomo sapiens (human)Ki1.700011
phencyclidineHomo sapiens (human)IC501.258911
phencyclidineHomo sapiens (human)Ki0.032433
2,3-dihydroxyquinoxalineHomo sapiens (human)IC5051,169.400022
glutamic acidHomo sapiens (human)IC500.070022
eliprodilHomo sapiens (human)Ki0.013099
budipineHomo sapiens (human)Ki11.700011
6,7-dichloroquinoxaline-2,3-dioneHomo sapiens (human)IC50281,171.400022
ly 293558Homo sapiens (human)IC5012.100011
besonprodilHomo sapiens (human)IC500.006044
besonprodilHomo sapiens (human)Ki0.030011
dizocilpineHomo sapiens (human)IC500.009011
dizocilpineHomo sapiens (human)Ki0.004012
cns 5161Homo sapiens (human)Ki0.001911
cp 101,606Homo sapiens (human)IC500.037033
cp 101,606Homo sapiens (human)Ki0.011022
6-methyl-2-(phenylethynyl)pyridineHomo sapiens (human)IC5018.000011
7-chloro-thiokynurenateHomo sapiens (human)IC505.000011
4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1h-pyrazol-1-yl)-4-oxobutanoic acidHomo sapiens (human)IC50113.000011
tcn 201Homo sapiens (human)IC5015.136544
l 745870Homo sapiens (human)Ki10.000011
levorphanolHomo sapiens (human)IC502.600022
dextromethorphanHomo sapiens (human)Ki1.680011
dextrorphanHomo sapiens (human)IC500.246011
dextrorphanHomo sapiens (human)Ki0.220011
licostinelHomo sapiens (human)IC502,944.223022
ro 25-6981Homo sapiens (human)IC500.024066
ro 25-6981Homo sapiens (human)Ki0.048644
eaa-090Homo sapiens (human)IC503.815022
pd 174494Homo sapiens (human)IC500.004522
fpl 15896arHomo sapiens (human)Ki0.560011
3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidineHomo sapiens (human)IC50300.000011
(4-benzylpiperidin-1-yl)-(6-hydroxy-1h-indol-2-yl)methanoneHomo sapiens (human)IC500.016022
tqx 173Homo sapiens (human)IC5046.000011
(1rs,1's)-peaqxHomo sapiens (human)IC5014.804022
methoxydineHomo sapiens (human)IC5015.848911
nitd 609Homo sapiens (human)IC5010.000011
wms 1410Homo sapiens (human)IC500.018511
wms 1410Homo sapiens (human)Ki0.049044

Drugs with Activation Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
spermineHomo sapiens (human)EC50126.000022
clofibric acidHomo sapiens (human)EC50300.000011
bezafibrateHomo sapiens (human)EC5060.000011
fenofibric acidHomo sapiens (human)EC50300.000011
25-hydroxycholesterolHomo sapiens (human)EC5010.000011
rosiglitazoneHomo sapiens (human)EC500.021011
pregnenolone sulfateHomo sapiens (human)EC5048.000022
24-hydroxycholesterolHomo sapiens (human)EC500.530011
(3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1h)-yl)methanoneHomo sapiens (human)EC5010.000011
gw 9578Homo sapiens (human)EC501.000011

Drugs with Other Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
felbamateHomo sapiens (human)Kapp6,444.50002020
licostinelHomo sapiens (human)Kb0.005011

Enables

This protein enables 9 target(s):

TargetCategoryDefinition
amyloid-beta bindingmolecular functionBinding to an amyloid-beta peptide/protein. [GOC:hjd]
NMDA glutamate receptor activitymolecular functionAn cation channel that opens in response to binding by extracellular glutmate, but only if glycine is also bound and the membrane is depolarized. Voltage gating is indirect, due to ejection of bound magnesium from the pore at permissive voltages. [GOC:mah, PMID:10049997]
protein bindingmolecular functionBinding to a protein. [GOC:go_curators]
zinc ion bindingmolecular functionBinding to a zinc ion (Zn). [GOC:ai]
glycine bindingmolecular functionBinding to glycine, aminoethanoic acid. [GOC:ai]
glutamate bindingmolecular functionBinding to glutamate, the anion of 2-aminopentanedioic acid. [GOC:ai]
glutamate-gated calcium ion channel activitymolecular functionEnables the transmembrane transfer of a calcium ion by a channel that opens when glutamate has been bound by the channel complex or one of its constituent parts. [GOC:mtg_transport, ISBN:0815340729]
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialmolecular functionAny ligand-gated ion channel activity, occurring in the presynaptic membrane, that is involved in regulation of presynaptic membrane potential. [GOC:dos, PMID:15145529, PMID:19558451]
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialmolecular functionAny transmitter-gated ion channel activity that is involved in regulation of postsynaptic membrane potential. [GO_REF:0000061, GOC:TermGenie, PMID:20200227]

Located In

This protein is located in 11 target(s):

TargetCategoryDefinition
cytoplasmcellular componentThe contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684]
lysosomecellular componentA small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions. [GOC:mah, ISBN:0198506732]
late endosomecellular componentA prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center. [NIF_Subcellular:nlx_subcell_20090702, PMID:11964142, PMID:2557062]
endoplasmic reticulum membranecellular componentThe lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah]
cytoskeletoncellular componentA cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. [GOC:mah, PMID:16959967, PMID:27419875]
plasma membranecellular componentThe membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363]
cell surfacecellular componentThe external part of the cell wall and/or plasma membrane. [GOC:jl, GOC:mtg_sensu, GOC:sm]
postsynaptic densitycellular componentAn electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components. [GOC:BHF, GOC:dos, GOC:ef, GOC:jid, GOC:pr, GOC:sjp, http://molneuro.kaist.ac.kr/psd, PMID:14532281, Wikipedia:Postsynaptic_density]
neuron projectioncellular componentA prolongation or process extending from a nerve cell, e.g. an axon or dendrite. [GOC:jl, http://www.cogsci.princeton.edu/~wn/]
postsynaptic membranecellular componentA specialized area of membrane facing the presynaptic membrane on the tip of the nerve ending and separated from it by a minute cleft (the synaptic cleft). Neurotransmitters cross the synaptic cleft and transmit the signal to the postsynaptic membrane. [ISBN:0198506732]
synaptic membranecellular componentA specialized area of membrane on either the presynaptic or the postsynaptic side of a synapse, the junction between a nerve fiber of one neuron and another neuron or muscle fiber or glial cell. [GOC:BHF, PMID:20410104]

Active In

This protein is active in 2 target(s):

TargetCategoryDefinition
plasma membranecellular componentThe membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363]
postsynaptic density membranecellular componentThe membrane component of the postsynaptic density. This is the region of the postsynaptic membrane in which the population of neurotransmitter receptors involved in synaptic transmission are concentrated. [GOC:dos]

Part Of

This protein is part of 1 target(s):

TargetCategoryDefinition
NMDA selective glutamate receptor complexcellular componentAn assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. NMDA receptors are composed of assemblies of NR1 subunits (Figure 3) and NR2 subunits, which can be one of four separate gene products (NR2A-D). Expression of both subunits are required to form functional channels. The glutamate binding domain is formed at the junction of NR1 and NR2 subunits. NMDA receptors are permeable to calcium ions as well as being permeable to other ions. Thus NMDA receptor activation leads to a calcium influx into the post-synaptic cells, a signal thought to be crucial for the induction of NMDA-receptor dependent LTP and LTD. [http://www.bris.ac.uk/Depts/Synaptic/info/glutamate.html]

Involved In

This protein is involved in 22 target(s):

TargetCategoryDefinition
glutamate receptor signaling pathwaybiological processThe series of molecular signals initiated by the binding of glutamate to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:mah, GOC:signaling, PMID:9131252]
chemical synaptic transmissionbiological processThe vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435]
brain developmentbiological processThe process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). [GOC:dph, GOC:jid, GOC:tb, UBERON:0000955]
learning or memorybiological processThe acquisition and processing of information and/or the storage and retrieval of this information over time. [GOC:jid, PMID:8938125]
calcium-mediated signalingbiological processAny intracellular signal transduction in which the signal is passed on within the cell via calcium ions. [GOC:signaling]
ionotropic glutamate receptor signaling pathwaybiological processThe series of molecular signals initiated by glutamate binding to a glutamate receptor on the surface of the target cell, followed by the movement of ions through a channel in the receptor complex, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:signaling, ISBN:0198506732]
response to ethanolbiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. [GOC:go_curators]
regulation of synaptic plasticitybiological processA process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. [GOC:dph, GOC:jid, GOC:tb, PMID:11891290]
regulation of neuronal synaptic plasticitybiological processA process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. [GOC:jid, PMID:11891290]
protein heterotetramerizationbiological processThe formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical. [GOC:go_curators]
positive regulation of synaptic transmission, glutamatergicbiological processAny process that activates, maintains or increases the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate. [GOC:ai]
calcium ion transmembrane import into cytosolbiological processA process in which a calcium ion is transported from one side of a membrane to the other into the cytosol by means of some agent such as a transporter or pore. [GOC:vw]
monoatomic cation transmembrane transportbiological processThe process in which a monoatomic cation is transported across a membrane. Monatomic cations (also called simple cations) are positively charged ions consisting of exactly one atom. [GOC:dos, GOC:vw]
excitatory chemical synaptic transmissionbiological processSynaptic transmission that results in an excitatory postsynaptic potential. [GOC:dos]
regulation of presynaptic membrane potentialbiological processAny process that modulates the potential difference across a presynaptic membrane. [GOC:dph, GOC:ef]
negative regulation of dendritic spine maintenancebiological processAny process that stops, prevents or reduces the frequency, rate or extent of dendritic spine maintenance. [GO_REF:0000058, GOC:sjp, GOC:TermGenie, PMID:24328732]
regulation of monoatomic cation transmembrane transportbiological processAny process that modulates the frequency, rate or extent of cation transmembrane transport. [GO_REF:0000058, GOC:TermGenie, PMID:15304482]
positive regulation of excitatory postsynaptic potentialbiological processAny process that enhances the establishment or increases the extent of the excitatory postsynaptic potential (EPSP) which is a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. [GOC:bf, GOC:BHF]
positive regulation of cysteine-type endopeptidase activitybiological processAny process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity. [GOC:obol]
long-term synaptic potentiationbiological processA process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse. [GOC:dgh, GOC:dph]
synaptic transmission, glutamatergicbiological processThe vesicular release of glutamate from a presynapse, across a chemical synapse, the subsequent activation of glutamate receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:dos]
excitatory postsynaptic potentialbiological processA process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. [GOC:dph, GOC:ef]